Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT06898840
CompletedNCT06898840ClinicalTrials.gov record

Establishing the Glycaemic Index of Fruit Drinks Using Different Measurement Methodologies

Glycaemic Index · Glycaemic Response Measurements

THE QUICK READ

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type
Interventional
Phase
Not applicable
Age range
18 years - 65 years
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
11 Actual

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

Glycaemic responses to carbohydrates ingested as fruit sugars may vary depending on factors inherent to the fruit and the type of sugar. The aim of this project is to investigate the glycaemic responses to a range of commercially available fruit drinks and to establish the glycaemic index for each product relative to a glucose reference. Differences in recorded responses could also be influenced by the sample type (capillary blood vs interstitial fluid) and participant characteristics. Participants will ingest 8 test drinks including 5 different fruit drinks (OJ, AJ, S\&B, ENERGISE, BLUE), each matched for carbohydrate to the glucose reference (CONTROL) which will be sampled two times, an additional sample of one of the smoothies (S\&B) will also be replicated. Fingerstick capillary blood sampling alongside dual sited continuous glucose monitors (CGM) will measure glucose and lactate concentrations, subjective appetite sensations will also be recorded. The tests will follow best practice guidelines for glycaemic index testing. These data will provide insight into how differing formulations can alter the glycaemic responses to fruit drinks, and whether sampling technique can affect the interpretations of measurement.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Age: 18-65 years
  • Body mass index 18-30 kg/m2

Exclusion Criteria:

  • diagnosis of any form of diabetes
  • intolerances or allergies to any of the study procedures (e.g. fructose/inulin intolerance)
  • Fructose malabsorption
  • Inborn errors of fructose metabolism (e.g. fructokinase deficiency, aldolase B deficiency, fructose-1,6-bisphosphatase deficiency)
  • pregnant or lactating
  • any condition that could introduce bias to the study (e.g. diagnoses of lipid disorders, including cardiovascular disease, or therapies that alter lipid or glucose metabolism, such as statins or niacin).
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Random assignment
Masking
No masking
CONTROL

50 g glucose (55 g dextrose powder accounting for hydration) plus 641 mL water

Other: Fruit drink

REPLICATE CONTROL

50 g glucose (55 g dextrose powder accounting for hydration) plus 641 mL water

Other: Fruit drink

S&B

417 mL of commercially available "Strawberries \& Bananas" fruit smoothie providing 50 g carbohydrate \[strawberries (31%), apples, bananas (22%), white grapes, oranges, blackcurrants\]. Plus 224 mL water to standardise volume

Other: Fruit drink

REPLICATE S&B

417 mL of commercially available "Strawberries \& Bananas" fruit smoothie providing 50 g carbohydrate \[strawberries (31%), apples, bananas (22%), white grapes, oranges, blackcurrants\]. Plus 224 mL water to standardise volume

Other: Fruit drink

OJ

641 mL of commercially available "Smooth Orange Juice" providing 50 g of carbohydrate \[100% oranges\]

Other: Fruit drink

AJ

455 mL commercially available "Apple Juice" providing 50 g of carbohydrate \[apples, ascorbic acid\]. Plus 186 mL water to standardise volume

Other: Fruit drink

ENERGISE

417 mL of commercially available "Energise Super Smoothie" providing 50 g carbohydrate \[apples (50%), red grapes, bananas, strawberries (10%), blackcurrants, sour cherries (3.3%), pressed beetroot, flax seeds (0.56%), guarana infusion (0.01%), vitamins B1, B2, B3, B6, C \& E\]. Plus 224 mL water to standardise volume

Other: Fruit drink

BLUE

521 mL of commercially available "Bolt from the Blue" juice drink providing 50 g carbohydrate \[apple (66%), coconut water (18%), white grapes, white guava (5.2%), passion fruit, lime (0.87%), spirulina extract (0.81%) vitamins B1, B2, B3, B6, C \& E\]. Plus 120 mL water to standardise volume

Other: Fruit drink

Fruit drink OTHER

Commercially available fruit drinks or smoothies

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Glycaemic indices for 5 test drinks measured using capillary blood samples

Time frame: 120 minutes

Glycaemic indices \[2-hour incremental area under the glucose curve (mmol/L-1x120 minutes) for each of the 5 test drinks relative to mean value of control conditions (CONTROL, REPLICATE CONTROL), expressed as a percentage\] in capillary blood samples

Secondary measures

Glycaemic index of all conditions with capillary blood samples vs CGM

Time frame: 120 minutes

The difference in glycaemic index \[2-hour incremental area under the glucose curve (mmol/L-1x120 minutes) for 5 test drinks relative to mean control (CONTROL, REPLICATE CONTROL), expressed as a percentage\] in capillary blood samples versus continuous glucose monitors.

Other measures

Comparisons between conditions in glucose concentration in capillary samples

Time frame: 120 minutes

Comparison of blood glucose concentration 2-hour incremental area under the curve (iAUC) min.mmol/L between test conditions

Comparisons between conditions in glucose concentration in capillary samples

Time frame: 120 minutes

Comparison of postprandial peak concentration mmol/L of blood glucose between test conditions (Cmax)

Comparisons between conditions in glucose concentration in capillary samples

Time frame: 120 minutes

Comparison of time to peak blood glucose concentration in minutes (Tmax) between test conditions

Comparisons between conditions in glucose concentration in capillary samples

Time frame: 120 minutes

Comparison of blood glucose concentration mmol/L at 2 hours between test conditions

Comparisons between conditions in glucose concentration with CGM

Time frame: 120 minutes

Comparison of glucose concentration 2-hour incremental area under the curve (iAUC) min.mmol/L between test conditions

Comparisons between conditions in glucose concentration with CGM

Time frame: 120 minutes

Comparison of postprandial peak concentration mmol/L of glucose between test conditions (Cmax)

Comparisons between conditions in glucose concentration with CGM

Time frame: 120 minutes

Comparison of time to peak glucose concentration in minutes (Tmax) between test conditions

Comparisons between conditions in glucose concentration with CGM

Time frame: 120 minutes

Comparison of glucose concentration mmol/L at 2 hours between test conditions

Comparisons between conditions in lactate concentration in capillary samples

Time frame: 120 minutes

Comparison of blood lactate concentration 2-hour incremental area under the curve (iAUC) min.mmol/L between test conditions

Comparisons between conditions in lactate concentration in capillary samples

Time frame: 120 minutes

Comparison of postprandial peak concentration mmol/L of blood lactate between test conditions (Cmax)

Comparisons between conditions in lactate concentration in capillary samples

Time frame: 120 minutes

Comparison of time to peak blood lactate concentration in minutes (Tmax) between test conditions

Comparisons between conditions in lactate concentration in capillary samples

Time frame: 120 minutes

Comparison of blood lactate concentration mmol/L at 2 hours between test conditions

Comparisons between conditions of appetite ratings

Time frame: 120 minutes

Comparison of subjective appetite sensations assessed with visual analogue scales (2-hour area under the curve min.mmVAS)

Comparisons between individuals

Time frame: 120 minutes

Comparison of Postprandial lactate concentration min.mmol/L between individuals 2-hour incremental area under curve (iAUC)

Comparisons between individuals

Time frame: 120 minutes

Comparison of Postprandial glucose concentration min.mmol/L between individuals 2-hour incremental area under curve (iAUC)

Comparisons between individuals

Time frame: 120 minutes

Comparison of Appetite rating responses min.mmVAS between individuals 2-hour area under curve (AUC)

Comparisons within individuals

Time frame: 120 minutes

Comparison within individuals of interstitial glucose concentrations measurements from continuous glucose monitors on left and right arms.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Department for Health, University of BathBath, United KingdomStatus unknown

Study team and timeline

Lead sponsor
University of Bath
Study start
Mar 13, 2025 Actual
Primary completion
Jul 9, 2025 Actual
Study completion
Jul 9, 2025 Actual
First posted
Mar 27, 2025 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.

Official study title

Study to Examine Glycaemic Responses to the Ingestion of Fruit Juices and Smoothies Using Different Measurement Methodologies.

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026